Your browser doesn't support javascript.
loading
Hollow-fiber liquid phase microextraction for determination of fluoxetine in human serum by nano-liquid chromatography coupled to high resolution mass spectrometry.
Isabella Cestaro, Beatriz; Cavalcanti Machado, Kelly; Batista, Michel; José Gonçalves da Silva, Bruno.
Afiliação
  • Isabella Cestaro B; Department of Chemistry, Federal University of Paraná, Curitiba 81531-980, Brazil.
  • Cavalcanti Machado K; Mass Spectrometry Facility RPT02H, Carlos Chagas Institute, Fiocruz, Curitiba 81350-010, Brazil.
  • Batista M; Mass Spectrometry Facility RPT02H, Carlos Chagas Institute, Fiocruz, Curitiba 81350-010, Brazil.
  • José Gonçalves da Silva B; Department of Chemistry, Federal University of Paraná, Curitiba 81531-980, Brazil. Electronic address: brunojose@ufpr.br.
Article em En | MEDLINE | ID: mdl-38286102
ABSTRACT
Therapeutic drug monitoring (TDM) is a personalized care tool based on the determination of a target drug concentration in human serum. An antidepressant drug of interest for such investigations is fluoxetine (FXT), due to a severe impact of genetic polymorphisms on its metabolism. A bioanalytical method employed for TDM purposes must exhibit satisfactory selectivity and detectability, which becomes more difficult due to highly complex biological matrices. In this study, a highly selective bioanalytical method for the determination of FXT in human serum is proposed, which provides excellent clean-up efficiency based on a low cost hollow fiber liquid-phase microextraction (HF-LPME) sample preparation step and nano-liquid chromatography coupled to high-resolution mass spectrometry (nano-LC-HRMS). HF-LPME was performed using a two-phase "U" configuration, with 6 cm fiber, 20 µL of 1-octanol acting as supported liquid membrane, and ammonium hydroxide (pH 10) as the donor phase with NaCl (10 % m/v) and methanol (5 % v/v) as additives, requiring only 250 µL of the sample. The procedure was conducted for 30 min under a 750 rpm stirring rate. Gradient elution was carried out employing an acetonitrile-water as mobile phase, the composition of 3070 to 10000 (v/v) for 15 min, using formic acid 0.1 % (v/v) as an additive. MS1 was acquired in an Orbitrap mass analyzer, while MS2 was acquired in a linear trap quadrupole. Satisfactory linearity (Pearson's r = 0.99709) was obtained for a concentration range of 0.02 to 2.5 µg mL-1, which is compatible with the therapeutic and toxic range for FXT. The developed method presents adequate precision (1.61 to 7.45 %) and accuracy (95 to 114 %) and allows the dilution of high concentration samples in a 14 ratio (v/v), enabling its application for forensic serum samples. To our knowledge, this is the first study reporting a method based on HF-LPME and nano-LC-HRMS with any analytical purpose, especially with a TDM focus.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fluoxetina / Microextração em Fase Líquida Limite: Humans Idioma: En Revista: J Chromatogr B Analyt Technol Biomed Life Sci / J. chromatogr. B / Journal of chromatography. B (Print) Assunto da revista: ENGENHARIA BIOMEDICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fluoxetina / Microextração em Fase Líquida Limite: Humans Idioma: En Revista: J Chromatogr B Analyt Technol Biomed Life Sci / J. chromatogr. B / Journal of chromatography. B (Print) Assunto da revista: ENGENHARIA BIOMEDICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil